Apolipoprotein B emerges as best lipid predictor for Myocardial Infarction risk
The risk of myocardial infarction in patients with and without atherosclerosis is best predicted by the number of apolipoprotein B (apoB)-containing lipoproteins, and this risk is independent from the lipid content and type of lipoproteins typically measured and targeted for therapy, according to a new analysis.
The results, which showed that only apoB was associated with the risk of MI in a model that fully adjusted for other lipids and clinical factors, suggest that apoB "may be the primary driver of atherosclerosis" and that drug therapy should target all apoB-containing lipoproteins to reduce the risk of adverse cardiovascular events.
For more details, check out the full story on the link below:
ApoB More Accurate Than LDL Or Non-HDL Cholesterol In Predicting Future MI Risk, JAMA Study
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd